[Clinical and economic evaluation of the introduction of the combinazion trametinib + dabrafenib in the management of advanced melanoma in the Italian market]. (2016). Farmeconomia. Health Economics and Therapeutic Pathways, 17(3S), 1-32. https://doi.org/10.7175/fe.v17i3S.1279